Description
GLYMPA 25/5 mg Tablets – 30’s
GLYMPA Tablets combine Teneligliptin 25 mg and Metformin 500 mg (extended-release) in a single, effective formulation designed to manage type 2 diabetes mellitus. This combination targets blood glucose control through complementary mechanisms: Teneligliptin enhances insulin secretion and suppresses glucagon release, while Metformin decreases hepatic glucose production and improves insulin sensitivity.
The extended-release Metformin ensures a gradual absorption, minimizing gastrointestinal side effects and promoting once-daily dosing for improved patient adherence.
GLYMPA 25/5 mg is typically prescribed when blood sugar levels are not adequately controlled by monotherapy or lower doses, helping patients achieve better glycemic control alongside diet and exercise.
Key Features:
-
Contains 25 mg Teneligliptin and 500 mg Metformin XR per tablet
-
Dual-action therapy for effective blood glucose management
-
Extended-release Metformin reduces side effects and enhances compliance
-
Enhances insulin secretion and reduces liver glucose output
-
Convenient once-daily dosing regimen
-
Pack of 30 tablets for a one-month supply
Usage:
Take as directed by a healthcare professional. Regular monitoring of blood glucose is recommended to ensure effective control.
Reviews
There are no reviews yet.